Stockscreener 앱 받기
0.5024
6.44%
0.0304
시간 외 거래:
.50
-0.0024
-0.48%
전일 마감가:
$0.472
열려 있는:
$0.4714
하루 거래량:
37,869
Relative Volume:
0.42
시가총액:
$66.85M
수익:
$78.46M
순이익/손실:
$2.75M
주가수익비율:
50.24
EPS:
0.01
순현금흐름:
$-12.42M
1주 성능:
+4.69%
1개월 성능:
+6.89%
6개월 성능:
-5.40%
1년 성능:
-40.89%
1일 변동 폭
$0.47
$0.5097
1주일 범위
$0.3901
$0.54
52주 변동 폭
$0.331
$0.96
엑스탄트 Stock (XTNT) Company Profile
명칭
Xtant Medical Holdings Inc
전화
406-388-0480
주소
664 Cruiser Lane, Belgrade, MT
XTNT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XTNT
Xtant Medical Holdings Inc
|
0.5024 | 66.85M | 78.46M | 2.75M | -12.42M | 0.01 |
|
ABT
Abbott Laboratories
|
132.60 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.24 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
381.36 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.45 | 107.01B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.11 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
엑스탄트 Stock (XTNT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-05 | 개시 | BTIG Research | Buy |
| 2018-11-15 | 재확인 | Maxim Group | Buy |
| 2018-02-14 | 재확인 | Maxim Group | Buy |
엑스탄트 주식(XTNT)의 최신 뉴스
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Shares Acquired by Renaissance Technologies LLC - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
How to interpret Xtant Medical Holdings Inc (XTNT)’s stock chart patterns - uspostnews.com
Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance - GuruFocus
Revolutionary Bone Graft Technology: Xtant Medical Unveils Trivium With 20-Year Proven Process - Stock Titan
Analysts Offer Insights on Healthcare Companies: Viatris (VTRS), Xtant Medical Holdings (XTNT) and Medtronic (MDT) - The Globe and Mail
Xtant Medical Holdings Inc (AMEX: XTNT) Has Great Upside Potential - stocksregister.com
Xtant Medical announces secondary private sale of existing shares - Medical Buyer
Xtant Medical Ends Investor Agreement After Share Sale - TipRanks
Xtant Medical secures investor support, projects Q1 revenue growth By Investing.com - Investing.com South Africa
Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19% - Ortho Spine News
Xtant Medical Announces Secondary Private Sale Of Existing Shares By Orbimed - marketscreener.com
Major Shakeup: OrbiMed Sells Entire Xtant Medical Stake as Revenue Surges 19% - Stock Titan
Orbimed advisors sells Xtant Medical stock for $30.7 million - Investing.com
Xtant Medical shares change hands in major stock purchase - Investing.com
Xtant Medical shares change hands in major stock purchase By Investing.com - Investing.com India
Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus - ACCESS Newswire
Xtant Medical (NYSEAMERICAN:XTNT) Shares Cross Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Spinal Fusion Device Market Forecast Report and Company Analysis 2025-2033 Featuring Medtronic, Stryker, Zimmer Biomet, Orthofix Medical, NuVasive, Globus Medical, Xtant Medical, and Alphatec – Ortho Spine News - OrthoSpineNews
Spinal Fusion Device Market Forecast Report and Company - GlobeNewswire
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Xtant Medical Faces Risk of Share Distribution by Major Stakeholder, Threatening Stock Stability - MSN
Xtant Medical Holdings, Inc. (AMEX:XTNT) Q4 2024 Earnings Call Transcript - Insider Monkey
Xtant Medical’s Earnings Call: Mixed Outlook with Growth Plans - TipRanks
Earnings call transcript: Xtant Medical Q4 2024 misses EPS, stock drops - Investing.com India
Earnings call transcript: Xtant Medical Q4 2024 misses EPS, stock drops By Investing.com - Investing.com South Africa
Xtant Medical stock target cut to $2 at BTIG, retains buy rating By Investing.com - Investing.com South Africa
Xtant Medical stock target cut to $2 at BTIG, retains buy rating - Investing.com
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Update - Defense World
Xtant Medical Reports Strong 2024 Revenue Growth - TipRanks
Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial Results - Yahoo Finance
Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025 - Yahoo Finance
Investor Network: Xtant Medical Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Xtant Medical (NYSEAMERICAN:XTNT) Stock Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Sees Large Drop in Short Interest - MarketBeat
Xtant Medical Holdings Inc (AMEX: XTNT) – An Analysis Is What You Need - Stocks Register
Xtant Medical (NYSEAMERICAN:XTNT) Shares Pass Above 200-Day Moving AverageHere's What Happened - MarketBeat
Spinal Implants Market to Grow by USD 3.55 Billion from 2025-2029, Driven by Rising Spinal Disorder Prevalence, AI's Impact on Market TrendsTechnavio - The Malaysian Reserve
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above 200 Day Moving AverageHere's Why - MarketBeat
Xtant Medical (NYSEAMERICAN:XTNT) Shares Cross Above 200 Day Moving Average – Should You Sell? - Defense World
엑스탄트 (XTNT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
11.62%
0.20%
자본화:
|
볼륨(24시간):